VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹716 Cr | ₹627 Cr | ₹601 Cr | ₹579 Cr | ₹556 Cr |
What is the latest Total Liabilities ratio of VENUS REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹716 Cr |
| Mar2024 | ₹627 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹579 Cr |
| Mar2021 | ₹556 Cr |
How is Total Liabilities of VENUS REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹716 Cr | 14.18 | |
| Mar2024 | ₹627 Cr | 4.28 | |
| Mar2023 | ₹601 Cr | 3.79 | |
| Mar2022 | ₹579 Cr | 4.19 | |
| Mar2021 | ₹556 Cr | - | |
Compare Total Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,332.2 Cr | 7.7% | 31.6% | 201.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 7.7% |
31.6% |
201.5% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses